BIOTIME INC Sales Agreements
2 Contracts & Agreements
- Sales Agreement, dated March 22, 2024, by and between Lineage Cell Therapeutics, Inc. and B. Riley Securities, Inc (Filed With SEC on March 22, 2024)
- Amendment No. 1 to Controlled Equity OfferingSM Sales Agreement, dated March 26, 2014, between BioTime, Inc. and Cantor Fitzgerald & Co (Filed With SEC on March 26, 2014)